Offer Mi~Scan® and Mi~Scan+®

Fast, personalised breast cancer risk score, including density, for all women

Breast cancer is the most diagnosed cancer in women worldwide1. Early detection saves lives yet millions of women still don’t know a critical risk factor: their breast density.

With Mi~Scan® and Mi~Scan+®, you can offer a groundbreaking, non-invasive solution that helps women understand their breast cancer risk quickly, clearly, and comfortably – no compression, no harmful radiation, no hospital visit.

1World Health Organisation

Are you a clinic, pharmacy, wellness provider or women’s health provider?

Stand out.
Attract clients.
Deliver impact.

Mi~Scan® and Mi~Scan+® are ideal add-on services for:

  • Private clinics and diagnostic centres
  • Pharmacies, spas and wellness studios
  • Women’s health clinics
  • Health screening and occupational health providers

No medical staff required, and we support you with full training and patient materials. You focus on delivering stand-out services, we handle the rest.

Are you looking to support employee wellbeing with meaningful, inclusive benefits?

Attract talent.
Promote workplace wellness.

Offer Mi~Scan® and Mi~Scan+® as part of your corporate health benefits:

  • Attract and retain talent with a standout female health benefit
  • Address DEI goals by closing the gender health gap
  • Demonstrate your businesses commitment to care and inclusion

Available onsite or through our clinic network. Flexible plans to suit all organisations.

Are you interested in becoming a Micrima distributor?

Expand access.
Grow your portfolio.
Drive innovation in women’s health.

We’re seeking regional and international distribution partners to help scale Mi~Scan® and Mi~Scan+®

Whether you’re an established healthcare distributor, medical technology provider, or women’s health entrepreneur, we offer:

  • Exclusive territory opportunities
  • Comprehensive training and marketing support
  • Flexible pricing and margin structures
  • Backed by expert clinicians and leading risk models (BOADICEA, Tyrer-Cuzick)

Be part of a mission to redefine breast cancer diagnostics and build a valuable new revenue stream.

Why partner with Mi~Scan® and Mi~Scan+®

  • Fast, non-invasive screening

  • Personalised risk results in minutes

  • No harmful radiation or compression

  • Clear reports clients can interpret themselves

  • No capital investment required

  • Revenue-share and flexible packages available

  • Full onboarding, training and support provided

What happens after the scan?

  • Clients receive instant, easy-to-understand reports

  • Option to track changes over time with repeat scans

  • Ongoing partner support and access to digital tools

Whether you are an entrepreneur, independent or multinational business this is your opportunity to deliver more than a benefit – deliver peace of mind, empowerment, and early action.

Let’s redefine breast cancer diagnostics together

Sign up with your email address to receive news and updates.